Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?
dc.contributor.author | Mazulis, Fernando | * |
dc.contributor.author | Weilg, Claudia | * |
dc.contributor.author | Alva Urcia, Carlos Alberto | * |
dc.contributor.author | Pons, Maria J | * |
dc.contributor.author | Del Valle Mendoza, Juana | * |
dc.date.accessioned | 2016-01-29T18:17:48Z | es_PE |
dc.date.available | 2016-01-29T18:17:48Z | es_PE |
dc.date.issued | 2015-01 | es_PE |
dc.identifier.citation | : Mazulis F, et al., Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?, Asian Pacific Journal of Tropical Medicine (2015), http://dx.doi.org/10.1016/j.apjtm.2015.11.014 | es_PE |
dc.identifier.issn | 1995-7645 | es_PE |
dc.identifier.pmid | 26706684 | es_PE |
dc.identifier.doi | 10.1016/j.apjtm.2015.11.014 | es_PE |
dc.identifier.uri | http://hdl.handle.net/10757/595273 | es_PE |
dc.description.abstract | Glucose-6-phosphate dehydrogenase (G6PD) is a cytoplasmic enzyme with an important function in cell oxidative damage prevention. Erythrocytes have a predisposition towards oxidized environments due to their lack of mitochondria, giving G6PD a major role in its stability. G6PD deficiency (G6PDd) is the most common enzyme deficiency in humans; it affects approximately 400 million individuals worldwide. The overall G6PDd allele frequency across malaria endemic countries is estimated to be 8%, corresponding to approximately 220 million males and 133 million females. However, there are no reports on the prevalence of G6PDd in Andean communities where bartonellosis is prevalent. | |
dc.format | application/pdf | es_PE |
dc.language.iso | eng | es_PE |
dc.publisher | Elsevier B.V. | es_PE |
dc.relation.url | https://www.researchgate.net/publication/284136837_Is_glucose-6-phosphate_dehydrogenase_deficiency_more_prevalent_in_Carrion's_disease_endemic_areas_in_Latin_America | es_PE |
dc.rights | info:eu-repo/semantics/openAccess | es_PE |
dc.source | Universidad Peruana de Ciencias Aplicadas (UPC) | es_PE |
dc.source | Repositorio Académico - UPC | es_PE |
dc.subject | Glucose-6-phosphate | es_PE |
dc.subject | Dehydrogenase | es_PE |
dc.subject | G6PD | es_PE |
dc.subject | Bartonella | es_PE |
dc.subject | Febrile syndrome | es_PE |
dc.title | Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America? | es_PE |
dc.type | info:eu-repo/semantics/article | es_PE |
dc.identifier.journal | Asian Pacific journal of tropical medicine | es_PE |
refterms.dateFOA | 2018-06-17T19:42:55Z | |
html.description.abstract | Glucose-6-phosphate dehydrogenase (G6PD) is a cytoplasmic enzyme with an important function in cell oxidative damage prevention. Erythrocytes have a predisposition towards oxidized environments due to their lack of mitochondria, giving G6PD a major role in its stability. G6PD deficiency (G6PDd) is the most common enzyme deficiency in humans; it affects approximately 400 million individuals worldwide. The overall G6PDd allele frequency across malaria endemic countries is estimated to be 8%, corresponding to approximately 220 million males and 133 million females. However, there are no reports on the prevalence of G6PDd in Andean communities where bartonellosis is prevalent. |
Files in this item
This item appears in the following Collection(s)
-
Medicina [970]